Drug Release Control Articles & Analysis
26 articles found
Linker Optimization: The linker serves a crucial function in maintaining stability, controlling drug release, and ensuring effective delivery of the cytotoxic drug. ...
This versatility is essential for developing sustained-release drug delivery systems. On the other hand, PEG copolymers tend to have a moderate drug loading capacity, making them more suitable for hydrophilic drugs. ...
This enhancement in solubility and bioavailability is crucial for the successful development of oral medications and other formulations where absorption efficiency is key. Controlled and Sustained Release Nanotechnology enables the formulation of drugs with controlled and sustained release profiles. ...
They are widely used in the pharmaceutical and biotechnology industries for drug delivery, controlled release systems, and other applications due to their unique properties and versatility. ...
Dendrimers have attracted much attention in drug delivery, imaging, and materials science due to their unique structure, high monodispersity, and tunable properties. ...
The field of pharmaceuticals has seen rapid advancements in drug delivery technologies in recent years, one of which is long-lasting controlled-release microspheres technology. ...
For example, through carboxylic acid functional groups, PEGs can covalently bind to drugs, targeting ligands, or other biologically active molecules, thus enabling drug-targeted delivery and controlled release. ...
In SN38-BSA bioconjugate, a type of bioconjugate called a protein-drug conjugate is created. Here, the drug (SN38) is directly linked to BSA. ...
Transdermal drug delivery formulations include creams, applicators, skeleton-type patches, membrane-controlled patches, microemulsions, liposomes, etc., which can produce local or systemic effects. ...
Polymer nanoparticles can also be engineered to release drugs in a controlled manner, increasing their efficacy and reducing potential side effects. ...
Liposomes: Liposomes can be used to deliver a variety of drugs, whether they are hydrophobic or hydrophilic, as the drugs can be embedded in the bilayer of the liposomes or inside the liposomes. ...
Biopharma PEG, a leading innovator in polyethylene glycol (PEG) derivatives, proudly introduces its featured Azide PEG series, which can be used in drug development, click chemistry, ADCs (Antibody Drug Conjugates), PROTACs (Proteolysis Targeting Chimeras), and beyond. ...
Over the years, several innovative drug delivery systems have been developed to improve drug efficacy and patient outcomes. ...
The controlled release of drugs from microspheres provides sustained drug delivery, ensuring a prolonged therapeutic effect and reducing dosing frequency. ...
Upon application to the skin, the microneedles dissolve, releasing the drug payload in response to the skin's temperature. This technology enables precise control over drug release kinetics, making it suitable for various therapeutic applications. ...
EVA also offers good flexibility, biocompatibility, and controlled drug release, making it a preferred choice in transdermal patches. Polypropylene Polypropylene is another excipient commonly employed in transdermal drug delivery systems due to its excellent barrier properties. It acts as a protective layer by preventing ...
Microencapsulation technology has revolutionized drug delivery systems, allowing for the protection and controlled release of therapeutic agents. ...
A personalised approach that reduces patient dosing burdens may improve compliance and engagement. Controlled-release drug delivery is one of the front-running solutions in this arena. The clue is in the name. Controlled-release drugs deliver active compounds at a programmed rate. ...
Once injected into the body, microspheres are gradually degraded in the body, allowing the drug to be released slowly at a certain rate, maintaining the drug concentration in the blood at the site of the lesion, thereby prolonging the half-life of the drug and achieving long-acting sustained release. ...
Polylactic acid and its copolymers can be made into specific pharmaceutical dosage forms based on the nature of the drug, the release requirements, and the route of administration. For example, the release rate of the drug can be adjusted by selecting lactic acid copolymers with different molecular weights and different ...